Roche is trading at $55.45, up +3.03%, alongside a healthcare sector gaining 1.37% in regular trading.

  • The S&P 500, Nasdaq, and Dow are each gaining more than 1%, supporting risk-on sentiment.
  • No fresh company-specific announcement was identified for September 3, 2026. Roche’s FDA clearance for its Alzheimer’s blood test was announced August 24, not September 3.